Home finds
 

Keywords :   


Tag: finds

Study finds key GSK-Theravance lung drug didn't extend lives

2015-09-09 01:33:31| Biotech - Topix.net

A closely watched study of GlaxoSmithKline plc's Breo Ellipta respiratory treatment failed to prove that it extends patients' lives, denying the drugmaker a much-needed marketing edge in its most lucrative - but declining - medicine category. It was a disappointing deja vu for the British drugmaker, which previously failed to prove the same benefit for its much older respiratory treatment Advair, long the company's top seller with revenue of $8.3 billion as recently as 2013.

Tags: key study lives drug

 

Extreme preemies make survival gains, 20-year study finds

2015-09-08 19:18:34| Biotech - Topix.net

A new study says many extremely premature infants now have a better chance of surviving without major problems. Still, odds remain poor for the tiniest, born nearly four months early.

Tags: make study extreme finds

 
 

Ford survey in Europe finds SUVs highly desired by Millenials; projected acceleration of SUV boom

2015-09-08 10:55:34| Green Car Congress

Tags: europe highly survey ford

 

Infosys: US finds no violations in H-1B visa case

2015-09-08 10:40:09| IT Services - Topix.net

The US had initiated investigation against Infosys and its larger rival Tata Consultancy Services for possible violations of H-1B visa rules in June. NEW YORK: India's second largest software services firm Infosys said the US government has found no visa violations after a probe that began in June this year.

Tags: case visa finds violations

 

North Shore-LIJ study of blood thinners finds no advantage to much more costly drug

2015-09-06 20:05:54| Biotech - Topix.net

Dr. Peter Berger, senior vice president for clinical research with the North Shore-LIJ Health System, assessed data from a large clinical trial and said Angiomax, a drug that is 400 times more expensive than old-fashioned heparin, may not be worth the cost during placement of a stent to open a clogged artery. Photo Credit: NSLIJ Dr. Peter Berger, senior vice president for clinical research with the North Shore-LIJ Health System, assessed data from a large clinical trial and said Angiomax, a drug that is 400 times more expensive than old-fashioned heparin, may not be worth the cost during placement of a stent to open a clogged artery.

Tags: north study advantage blood

 

Sites : [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] next »